2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.32+$0.04 (+1.25%)
Price as of Aug 21, 2026 7:32 PM EDT- $714.7MMarket Cap
- 54.72%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.32+$0.04 (+1.25%)
CTMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.28 | ||
Change | -$0.01 (-0.30%) | ||
Open | $3.31 | ||
High | $3.42 | ||
Low | $3.27 | ||
Previous Close | $3.29 | ||
Volume | 2,894,719 | ||
30-Day Average Volume | 2,311,460 | ||
1-Week Change | -2.38% | ||
1-Month Change | -4.09% | ||
1-Year Change | 54.72% | ||
3-Year Change | 121.62% | ||
5-Year Change | -29.61% | ||
Fundamentals | |||
Shares Outstanding | 217.9M | ||
Total Assets | $381.2M | ||
Market Cap | $714.7M | ||
Enterprise Value | $697.5M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.7M | ||
Free Cash Flow | -$18.1M | ||
EBIT | -$20.6M | ||
EBITDA | -$20.6M | ||
Net Working Capital | $333.3M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 492 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue